Catalent to Acquire Cook Pharmica for $950M

Catalent said today it agreed to acquire Cook Pharmica for $950 million in a deal that would continue the consolidation of contract development and manufacturing organizations (CDMOs), to which biopharmas have increasingly outsourced operations, and bolster the buyer’s biologics capabilities.The acquisition would join Cook Pharmica’s drug substance and drug product manufacturing and related services with Catalent’s development, delivery, and supply operations—creating a c